Medical News

RSS

Reductions in obesity-related medical costs offset cost of gastric banding surgery within 2.25 years

Allergan, Inc. today announced a new study published in the peer-reviewed journal Surgery for Obesity and Related Diseases that found the cost of a gastric banding weight-loss surgery procedure, such as Allergan's LAP-BAND Adjustable Gastric Banding System, was offset by reductions in obesity-related medical costs within 2.25 years for surgery eligible patients with diabetes, and within four years of the procedure for all surgery eligible patients.

23 Jun 2011

Arno AR-67 Phase II clinical study for glioblastoma meets pre-defined interim goals

Arno Therapeutics, Inc. announced today that its Phase II clinical study of AR-67 has met pre-defined interim goals for patients with glioblastoma multiforme (GBM) who were not previously treated with Avastin and will continue toward completion.

23 Jun 2011

Majority of cancers are due to epigenetic influences

Dr. Ajay Goel, Ph.D., Director of Epigenetics and Cancer Prevention at the Gastrointestinal Research Center at Baylor University Medical Center in Dallas, TX, has announced plans for a series of upcoming studies to continue to unlock the mechanisms by which curcumin prevents cancer via its influence on epigenetic activity.

23 Jun 2011

Varian receives 2011 R&D 100 Award for TrueBeam system for image-guided radiotherapy and radiosurgery

Varian Medical Systems today announced that the company's TrueBeam system for image-guided radiotherapy and radiosurgery has received a 2011 R&D 100 Award from R&D Magazine. This annual award salutes the 100 most technologically significant products of the prior year, spanning many categories, from biomedical products to consumer items.

23 Jun 2011

Health Canada approves PURE Hard Surface disinfectant

PURE Bioscience, Inc., creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that Health Canada has approved PURE™ Hard Surface disinfectant for use in food premises, hospitals and health care facilities, domestic locations and institutional and industrial premises.

23 Jun 2011

Cyanotech fourth quarter revenues increase to $5,218,000

Cyanotech Corporation, a world leader in microalgae-based, high-value nutrition and health products, today announced financial results for the fourth quarter and fiscal year 2011, ended March 31, 2011.

23 Jun 2011

FDA grants fast track designation to Synageva for SBC-102 program for Lysosomal Acid Lipase Deficiency

Synageva BioPharma Corp., a privately held biopharmaceutical company developing therapeutic products for rare disorders, announced today that their lead program, SBC-102, an enzyme replacement therapy for Lysosomal Acid Lipase (LAL) Deficiency, currently in clinical trials, has been granted fast track designation by the U.S. Food and Drug Administration (FDA).

23 Jun 2011

MU and Coulter Foundation enter $5 million grant agreement for biomedical research

University of Missouri officials announced today a $5 million grant agreement with the Wallace H. Coulter Foundation, through the Foundation's Translational Partnership Award Program. The goal of the partnership is to develop technologies that will save, extend and improve patient lives and suffering from any disease or condition in any country around the world.

23 Jun 2011

Spinal manipulative therapy provides minor but significant benefits for patients with chronic low back pain

Spinal manipulative therapy (SMT) has significant but very small benefits for patients with chronic low back pain, according to a special review article in the June 1 issue of Spine.

23 Jun 2011

Surgery for children motivates smoking parents to try to quit

A study published in the July issue of Anesthesiology has found that parents who smoke are more likely to attempt to quit during the time of their child's surgery - but that they are not more likely to succeed. According to the study, these facts suggest that physicians could play an important role in assisting smokers with kicking the habit during this time.

23 Jun 2011

GAD vaccine DIAPREV-IT study in high-risk children continues as planned

Despite the disappointing results in trying to treat children suffering from type 1 diabetes with the GAD vaccine, the treatment has not been written off entirely. DIAPREV-IT, the study in which healthy high-risk children are vaccinated, is continuing as planned, and now with more money behind it. "I am still hopeful that the GAD vaccine will work", says Helena Elding Larsson.

23 Jun 2011

Michelle Obama talks about AIDS, women's rights on Africa trip

First Lady Michelle Obama, who is on a trip to Africa, "urged young Africans on Wednesday to fight for women's rights and battle the stigma of AIDS, using her husband's 'yes, we can' campaign slogan to motivate youth across the continent," Reuters reports.

23 Jun 2011

New proteomics-based approach to analyze bone quality

A new technique developed at Rensselaer Polytechnic Institute allows researchers to collect large amounts of biochemical information from nanoscale bone samples.

23 Jun 2011

Funding vaccines in the developing world creates positive allies

Syndicated columnist and ONE senior adviser Michael Gerson, in a CNN opinion piece, reviews the documentary "Voodoo and Vaccines," which he writes "shows how government and health officials have reached out to religious leaders, and how many traditional healers are now carrying a pro-vaccination message.

23 Jun 2011

Resveratrol may make old age more tolerable, but not prevent it

A University of Florida review of research finds the polyphenol compound known as resveratrol found in red wine, grapes and other fruits may not prevent old age, but it might make it more tolerable.

23 Jun 2011

PNP Pharmaceuticals contracted as exclusive global manufacturer of Fero Industries' Sucanon

Fero Industries, Inc. is pleased to announce that it has contracted PNP Pharmaceuticals Inc. as the exclusive global manufacturer of Sucanon®, an oral treatment for type-2 diabetes.

23 Jun 2011

Silicone gel-filled breast implants: FDA releases updated data

The U.S. Food and Drug Administration released a report today updating the clinical and scientific information for silicone gel-filled breast implants, including preliminary safety data from studies conducted by the manufacturers as a condition of their November 2006 approval.

23 Jun 2011

First Edition: June 23, 2011

In today's headlines, reports that the Department of Health and Human Services will scale back the health law's rules on patient health care appeals.

23 Jun 2011

Gaining regulatory approval for new medical devices easier than convincing insurers to provide coverage

What's easier: gaining regulatory approval for a new medical device, or convincing insurers to cover the treatments it provides? According to Susan Klees of the Focused Ultrasound Surgery Foundation, many experts say regulatory approval is the easier task.

23 Jun 2011

FDA grants Fast Track designation for Repligen's RG3039 to treat Spinal Muscular Atrophy

Repligen Corporation announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for RG3039, a potential treatment for Spinal Muscular Atrophy.

23 Jun 2011

Medical News

Reductions in obesity-related medical costs offset cost of gastric banding surgery within 2.25 years

Arno AR-67 Phase II clinical study for glioblastoma meets pre-defined interim goals

Majority of cancers are due to epigenetic influences

Varian receives 2011 R&D 100 Award for TrueBeam system for image-guided radiotherapy and radiosurgery

Health Canada approves PURE Hard Surface disinfectant

Cyanotech fourth quarter revenues increase to $5,218,000

FDA grants fast track designation to Synageva for SBC-102 program for Lysosomal Acid Lipase Deficiency

MU and Coulter Foundation enter $5 million grant agreement for biomedical research

Spinal manipulative therapy provides minor but significant benefits for patients with chronic low back pain

Surgery for children motivates smoking parents to try to quit

GAD vaccine DIAPREV-IT study in high-risk children continues as planned

Michelle Obama talks about AIDS, women's rights on Africa trip

New proteomics-based approach to analyze bone quality

Funding vaccines in the developing world creates positive allies

Resveratrol may make old age more tolerable, but not prevent it

PNP Pharmaceuticals contracted as exclusive global manufacturer of Fero Industries' Sucanon

Silicone gel-filled breast implants: FDA releases updated data

First Edition: June 23, 2011

Gaining regulatory approval for new medical devices easier than convincing insurers to provide coverage

FDA grants Fast Track designation for Repligen's RG3039 to treat Spinal Muscular Atrophy

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Obesity, GLP-1s, and metabolic care

Latest News